New strategy aims to end AIDS in children by 2020
HIV treatment programmes need to prepare for the 'youth bulge', South African experience shows
ART use averting huge numbers of opportunistic infections among children living with HIV in lower-income countries
In Option B+, side-effects and needing time to think are key reasons for not taking HIV medication
Studies probe retention in HIV care for women who start antiretroviral treatment during pregnancy
Option B+ has enabled Malawi to make significant progress towards 90-90-90
Dolutegravir safe and highly effective in older children
Cotrimoxazole prophylaxis provides no benefit for HIV-exposed uninfected children
